Company Profile
Updated: 18-DEC-09Light Force Therapy Inc.
Private Company, Headquarters Location
1111 Gordon Creek Ln., Livermore, CO 80107-0306, United States
(970)482-8032, (360)251-1841 fax, http://www.lightfortherapy.com
Primary SIC: Electromedical Apparatus, Primary NAICS: Electromedical and Electrotherapeutic Apparatus Manufacturing
Description: Manufacturing: Electromedical Apparatus
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
AcceleDent System From OrthoAccel Technologies, Inc. Secures Medical Device Regulatory Clearance to Market in Australia.
Biotech Week; 11/25/2009; 849 words; ...OrthoAccel Technologies, Inc., developers of...OrthoAccel Technologies, Inc.). AcceleDent is...daily. It generates a light microvibration force which modulates the...OrthoAccel Technologies, Inc., U.S. Food and...Dental Device, Therapy, Treatment, Orthodontics...
Research conducted at National Institutes of Health has provided new information about malaria.
Vaccine Weekly; 11/18/2009; 819 words; ...both EcCSP and PpCSP by dynamic light scattering and velocity sedimentation...Furthermore, high resolution atomic force microscopy revealed flexible...Biochemistry Molecular Biology Inc., 9650 Rockville Pike, Bethesda...Antibodies, Plasmodium falciparum, Therapy, Treatment, Tropical Disease...
CardioGenics Holdings Inc. Featured in Medical Device Daily.
PR Newswire; 11/13/2009; 920 words; ...CardioGenics Holdings Inc. (BULLETIN BOARD...intended as a more light-sensitive alternative...more conservative therapy." In the article...CardioGenics Holdings Inc. CardioGenics is...needs is the driving force behind CardioGenics...for improving the light collection from ...
Other News To Note.
BIOWORLD Today; 11/4/2009; 2389 words; ...to bring its work force to about 65 employees...o Applied Genetics Inc., of Freeport...o AVI BioPharma Inc., of Portland...Cellegy Pharmaceuticals Inc., of South San Francisco...is a photodynamic therapy being developed to...cells when exposed to light. o Cytos Biotechnology...
Pozen Starts Phase III Migraine Program, Hits $15M Milestone.
BIOWORLD Today; 11/3/2009; 1222 words; ...migraine drug Trexima, Pozen Inc. launched a Phase III...extreme sensitivity to light and sound. Researchers...Plachetka said. Pozen joined forces with GSK in June last...an oral first-line therapy to treat migraines. The...nausea, sensitivity to light and sensitivity to sound...
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning